Evaluation of the efficacy of Methylphenidate and modafinil in the treatment of excessive daily sleepiness in patients with drug-resistant epilepsy and comparison with the control group
Phase 1
Recruiting
- Conditions
- Epilepsy.Epilepsy and recurrent seizures
- Registration Number
- IRCT20171030037093N22
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
People with refractory epilepsy
Diagnosis of EDS by a neurologist
Hypersensitivity to methylphenidate and modafinil
Individual consent to participate in the study
Exclusion Criteria
Head trauma
Diagnosis of other neurologic diseases such as dementia
stroke
Thyroid diseases
Drug abuse
Liver or kidney failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of drowsiness. Timepoint: Before and after treatment. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method